132 related articles for article (PubMed ID: 20332497)
1. Improving osteoporosis screening, risk assessment, diagnosis, and treatment initiation: role of the health-system pharmacist in closing the gap.
MacLaughlin EJ
Am J Health Syst Pharm; 2010 Apr; 67(7 Suppl 3):S4-8. PubMed ID: 20332497
[TBL] [Abstract][Full Text] [Related]
2. Screening for osteoporosis in the adult U.S. population: ACPM position statement on preventive practice.
Lim LS; Hoeksema LJ; Sherin K;
Am J Prev Med; 2009 Apr; 36(4):366-75. PubMed ID: 19285200
[TBL] [Abstract][Full Text] [Related]
3. Managing cancer treatment-induced bone loss and osteoporosis in patients with breast or prostate cancer.
Michaud LB
Am J Health Syst Pharm; 2010 Apr; 67(7 Suppl 3):S20-30; quiz S31-3. PubMed ID: 20332495
[TBL] [Abstract][Full Text] [Related]
4. Pharmacist Screening for Risk of Osteoporosis in Elderly Veterans.
Salvig BE; Gulum AH; Walters SA; Edwards LB; Fourakre TN; Marvin SC; McKenzie MS; Moseley MV; Ansari IJ
Consult Pharm; 2016; 31(8):440-9. PubMed ID: 27535079
[TBL] [Abstract][Full Text] [Related]
5. The utility of dual-energy X-ray absorptiometry, calcaneal quantitative ultrasound, and fracture risk indices (FRAX® and Osteoporosis Risk Assessment Instrument) for the identification of women with distal forearm or hip fractures: A pilot study.
Esmaeilzadeh S; Cesme F; Oral A; Yaliman A; Sindel D
Endocr Res; 2016 Aug; 41(3):248-60. PubMed ID: 26864472
[TBL] [Abstract][Full Text] [Related]
6. Validation of three tools for identifying painful new osteoporotic vertebral fractures in older Chinese men: bone mineral density, Osteoporosis Self-Assessment Tool for Asians, and fracture risk assessment tool.
Lin J; Yang Y; Fei Q; Zhang X; Ma Z; Wang Q; Li J; Li D; Meng Q; Wang B
Clin Interv Aging; 2016; 11():461-9. PubMed ID: 27217730
[TBL] [Abstract][Full Text] [Related]
7. Screening for osteoporosis following non-vertebral fractures in patients aged 50 and older independently of gender or level of trauma energy-a Swiss trauma center approach.
Hemmeler C; Morell S; Amsler F; Gross T
Arch Osteoporos; 2017 Dec; 12(1):38. PubMed ID: 28391563
[TBL] [Abstract][Full Text] [Related]
8. Bone mineral density screening and its accordance with Canadian clinical practice guidelines from 2000-2013: an unchanging landscape in Saskatchewan, Canada.
McLeod KM; Johnson S; Charturvedi R; St Onge J; Lionel A; Verma A
Arch Osteoporos; 2015; 10():227. PubMed ID: 26173601
[TBL] [Abstract][Full Text] [Related]
9. Cost-Effectiveness of Osteoporosis Screening Strategies for Men.
Nayak S; Greenspan SL
J Bone Miner Res; 2016 Jun; 31(6):1189-99. PubMed ID: 26751984
[TBL] [Abstract][Full Text] [Related]
10. Primary care use of FRAX: absolute fracture risk assessment in postmenopausal women and older men.
Siris ES; Baim S; Nattiv A
Postgrad Med; 2010 Jan; 122(1):82-90. PubMed ID: 20107292
[TBL] [Abstract][Full Text] [Related]
11. The impact of the new National Bone Health Alliance (NBHA) diagnostic criteria on the prevalence of osteoporosis in the United States: supplementary presentation.
Wright NC; Saag KG; Dawson-Hughes B; Khosla S; Siris ES
Osteoporos Int; 2017 Nov; 28(11):3283-3284. PubMed ID: 28936598
[TBL] [Abstract][Full Text] [Related]
12. Use of Trabecular Bone Score (TBS) as a Complementary Approach to Dual-energy X-ray Absorptiometry (DXA) for Fracture Risk Assessment in Clinical Practice.
Shevroja E; Lamy O; Kohlmeier L; Koromani F; Rivadeneira F; Hans D
J Clin Densitom; 2017; 20(3):334-345. PubMed ID: 28734710
[TBL] [Abstract][Full Text] [Related]
13. The Fracture Risk Assessment Tool (FRAX®): applications in clinical practice.
Watts NB
J Womens Health (Larchmt); 2011 Apr; 20(4):525-31. PubMed ID: 21438699
[TBL] [Abstract][Full Text] [Related]
14. Application of the World Health Organization Fracture Risk Assessment Tool to predict need for dual-energy X-ray absorptiometry scanning in postmenopausal women.
Chao AS; Chen FP; Lin YC; Huang TS; Fan CM; Yu YW
Taiwan J Obstet Gynecol; 2015 Dec; 54(6):722-5. PubMed ID: 26700992
[TBL] [Abstract][Full Text] [Related]
15. Closing the osteoporosis management gap in primary care: a secondary prevention of fracture programme.
Brankin E; Mitchell C; Munro R;
Curr Med Res Opin; 2005 Apr; 21(4):475-82. PubMed ID: 15899094
[TBL] [Abstract][Full Text] [Related]
16. Utility of DXA screening for diagnosis of osteoporosis in US veterans aged 70 years and older.
Khatib J; Stote K; Gosmanov AR
J Investig Med; 2018 Feb; 66(2):298-303. PubMed ID: 28974557
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of decision rules to identify postmenopausal women for intervention related to osteoporosis.
Brenneman SK; Lacroix AZ; Buist DS; Chen YT; Abbott TA
Dis Manag; 2003; 6(3):159-68. PubMed ID: 14570384
[TBL] [Abstract][Full Text] [Related]
18. Screening for osteoporosis in men aged 70 years and older in a primary care setting in the United States.
Lim SY; Lim JH; Nguyen D; Okamura R; Amiri HM; Calmes M; Nugent K
Am J Mens Health; 2013 Jul; 7(4):350-4. PubMed ID: 23440083
[TBL] [Abstract][Full Text] [Related]
19. Osteoporosis Clinical Guideline. South African Medical Association--Osteoporosis Working Group.
Hough S
S Afr Med J; 2000 Sep; 90(9 Pt 2):907-44. PubMed ID: 11081144
[TBL] [Abstract][Full Text] [Related]
20. A comparison of electronic and manual fracture risk assessment tools in screening elderly male US veterans at risk for osteoporosis.
Williams ST; Lawrence PT; Miller KL; Crook JL; LaFleur J; Cannon GW; Nelson RE
Osteoporos Int; 2017 Nov; 28(11):3107-3111. PubMed ID: 28756457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
